Тезисы 2011 год
1. Novik A., Ionova T., Fedorenko D., Mochkin N., Kalyadina S., Kurbatova K., Nikitina T., Gorodokin G. Comprehensive Symptom Profile in patients undergoing BMT / PSCT: practicability and usefulness of the new symptom assessment tool. Bone Marrow Transplantation. 2011; 4(1): 182.
2. Novik A., Ionova T., Salek S. Dichotomous model to evaluate treatment outcomes in non-hodgkin's lymphoma patients. Haematologica. 2011; 96(2): 563.
3. Novik A., Kuznetsov A., Afanasiev B., Lisukov I., Rossiev V., Rukavicin O., Fedorenko D., Gridasov G., Ionova T., Kulagin A., Kurbatova K., Makarov S., Melnichenko V., Osipova N., Shamansky S., Gorodokin G. Long-term follow-up after autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplantation. 2011; 46(1): 85.
4. Novik A., Kuznetsov A., Afanasiev B., Lisukov I., Rossiev V., Rukavicin O., Fedorenko D., Gridasov G., Ionova T., Kulagin A., Kurbatova K., Makarov S., Melnichenko V., Osipova N., Shamansky S., Gorodokin G. Treatment outcomes in multiple sclerosis patients after autologous hematopoietic stem cell transplantation: analysis of 191 patients. Haematologica. 2011; 96(2): 233.
5. Novik A.A., Kuznetsov A.N., Afanasiev B.V., Lisukov I.A., Rossiev V.A., Rukavicin O.A., Melnichenko V.Y., Fedorenko D.A., Gridasov G.N., Ionova T.I., Kulagin A.D., Kurbatova K.A., Makarov S.V., Osipova N.E., Shamansky S.V., Gorodokin G.V. Early vs Late / salvage autologous hematopoietic stem cell transplantation in multiple sclerosis patients. Multiple Sclerosis. 2011; 17: 178.
6. Novik A., Kuznetsov A., Ionova T., Melnichenko V., Fedorenko D., Mochkin N., Kartashov A., Kurbatova K., Gorodokin G. Clinical and symptom profile in multiple sclerosis patients after autologous haematopoietic stem cell transplantation (AHSCT). European Journal of Neurology 2011, 18(2): 210.
7. Novik A., Kuznetsov A., Melnichenko V., Fedorenko D., Ionova T., Kartashov A., Kurbatova K., Gorodokin G. Controversies of autologous stem cell transplantation in multiple sclerosis. COSTEM. 2011.
8. Novik A.A., Kuznetsov A.N., Melnichenko V.Y., Fedorenko D.A., Ionova T.I., Kartashov A.V., Kurbatova K.A., Gorodokin G.V. Long-term follow-up after non-myeloablative autologous hematopoietic stem cell transplantation with consolidation therapy using mitoxantrone in multiple sclerosis. Multiple Sclerosis. 2011; 17: 178.
9. Novik A., Kuznetsov A., Melnichenko V., Fedorenko D., Ionova T., Kartashov A., Kurbatova K., Gorodokin G. Mini-autologous hematopoietic stem cell transplantation (AHSCT) +/– consolidation therapy in the posttransplant period for multiple sclerosis (MS) European Journal of Neurology. 2011; 18(2): 212.
10. Novik A., Melnichenko V., Fedorenko D., Ionova T., Kurbatova K., Gorodokin G. Non-myeloablative autologous stem cell transplantation with consolidation therapy using Mitoxantrone: treatment outcomes in 55 multiple sclerosis patients. Bone Marrow Transplantation. 2011; 46(1): 86.
11. Novik A., Vetshev P., Ionova T., Von S., Gorodokin G. Comprehensive symptom profile in patients with nontoxic goiters: practicability and sensitivity of the new symptom assessment tool CSP-ThSF22. Endocrine Abstracts. 2011; 26: 377.
12. Novik A., Vetshev P., Ionova T., Von S., Gorodokin G. Comprehensive symptom profile in patients with toxic goiters: practicability and sensitivity of the new symptom assessment tool CSP-ThHyperSF27. Endocrine Abstracts. 2011; 26: 379.
|
